SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-024908
Filing Date
2024-02-16
Accepted
2024-02-16 16:13:11
Documents
14
Period of Report
2024-02-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246476d1_8k.htm   iXBRL 8-K 28187
  Complete submission text file 0001104659-24-024908.txt   202800

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jagx-20240215.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20240215_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20240215_pre.xml EX-101.PRE 22379
15 EXTRACTED XBRL INSTANCE DOCUMENT tm246476d1_8k_htm.xml XML 3613
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 24648479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)